|Articles|March 21, 2007
MEEI drops litigation against QLT & Novartis
Litigation proceedings initiated by the Massachusetts Eye and Ear Infirmary (MEEI) in 2001 against QLT and Novartis Ophthalmics, have been settled.
Advertisement
Litigation proceedings initiated by the Massachusetts Eye and Ear Infirmary (MEEI) in 2001 against QLT and Novartis Ophthalmics, have been settled.
Under the terms of the agreement, MEEI will dismiss its claim that QLT and Novatis had infringed US Patent #6,225,303 and QLT and Novartis will dismiss its counterclaims against MEEI and named MEEI researchers.
However, a further patent lawsuit, brought in 2000 by MEEI against QLT, has yet to be resolved.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery
2
Oku Digital Health launches from Topcon to link eye care, primary care
3
EURETINA 2026: Optogenetic therapy MCO-010 aims to restore vision in advanced macular disease
4
EURETINA 2026: Eyestem interim Phase 2 results for clinical study of Eyecyte-RPE for GA secondary to dry AMD
5















